{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T20:33:26Z","timestamp":1769632406692,"version":"3.49.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy Research"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1016\/j.eplepsyres.2014.02.012","type":"journal-article","created":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T22:31:49Z","timestamp":1393713109000},"page":"634-643","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Pre-treatment with the NMDA receptor glycine-binding site antagonist L-701,324 improves pharmacosensitivity in a mouse kindling model"],"prefix":"10.1016","volume":"108","author":[{"given":"Christina","family":"Zellinger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josephine D.","family":"Salvamoser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonna","family":"Soerensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erwin A.","family":"van Vliet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eleonora","family":"Aronica","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Gorter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heidrun","family":"Potschka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.eplepsyres.2014.02.012_bib0005","doi-asserted-by":"crossref","first-page":"3333","DOI":"10.1021\/mp4001102","article-title":"Dynamic regulation of P-glycoprotein in human brain capillaries","volume":"10","author":"Avemary","year":"2013","journal-title":"Mol. Pharm."},{"issue":"6","key":"10.1016\/j.eplepsyres.2014.02.012_bib0010","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.neuropharm.2008.02.008","article-title":"Glutamate is critically involved in seizure-induced overexpression of P-glycoprotein in the brain","volume":"54","author":"Bankstahl","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.eplepsyres.2014.02.012_bib0015","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1124\/mol.107.041210","article-title":"Seizure-induced up-regulation of P-glycoprotein at the blood\u2013brain barrier through glutamate and cyclooxygenase-2 signaling","volume":"73","author":"Bauer","year":"2008","journal-title":"Mol. Pharm."},{"issue":"2\u20133","key":"10.1016\/j.eplepsyres.2014.02.012_bib0020","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0014-2999(97)00084-8","article-title":"Anticonvulsant effects by combined treatment with a glycineB receptor antagonist and a polyamine site antagonist in amygdala-kindled rats?","volume":"322","author":"Ebert","year":"1997","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.eplepsyres.2014.02.012_bib0025","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.eplepsyres.2010.06.012","article-title":"Targeting the prostaglandin E2 EP1 receptor and cyclooxygenase-2 in the amygdala kindling model in mice","volume":"91","author":"Fischborn","year":"2010","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2014.02.012_bib0030","series-title":"The mouse brain in stereotactic coordinates","author":"Franklin","year":"2004"},{"issue":"4","key":"10.1016\/j.eplepsyres.2014.02.012_bib0035","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.yebeh.2011.07.024","article-title":"The NMDA receptor complex as a therapeutic target in epilepsy: a review","volume":"22","author":"Ghasemi","year":"2011","journal-title":"Epilepsy Behav."},{"issue":"5","key":"10.1016\/j.eplepsyres.2014.02.012_bib0040","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1111\/j.1471-4159.1975.tb04395.x","article-title":"Isolation of metabolically active capillaries from rat brain","volume":"25","author":"Goldstein","year":"1975","journal-title":"J. Neurochem."},{"issue":"7\u20138","key":"10.1016\/j.eplepsyres.2014.02.012_bib0045","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S0223-5234(03)00113-2","article-title":"Antagonists and agonists at the glycine site of the NMDA receptor for therapeutic interventions?","volume":"38","author":"Jansen","year":"2003","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"10.1016\/j.eplepsyres.2014.02.012_bib0050","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0304-3940(97)00919-1","article-title":"Focal ischemia enhances the adverse effect potential of N-methyl-d-aspartate receptor antagonists in rats","volume":"240","author":"Loscher","year":"1998","journal-title":"Neurosci. Lett."},{"issue":"1","key":"10.1016\/j.eplepsyres.2014.02.012_bib0055","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1528-1167.2009.02183.x","article-title":"High seizure frequency prior to antiepileptic treatment is a predictor of pharmacoresistant epilepsy in a rat model of temporal lobe epilepsy","volume":"51","author":"Loscher","year":"2010","journal-title":"Epilepsia"},{"issue":"26","key":"10.1016\/j.eplepsyres.2014.02.012_bib0060","doi-asserted-by":"crossref","first-page":"2808","DOI":"10.2174\/138161211797440212","article-title":"Do ATP-binding cassette transporters cause pharmacoresistance in epilepsy? Problems and approaches in determining which antiepileptic drugs are affected","volume":"17","author":"Loscher","year":"2011","journal-title":"Curr. Pharm. Des."},{"issue":"4","key":"10.1016\/j.eplepsyres.2014.02.012_bib0065","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.neuropharm.2011.05.027","article-title":"Effects of high frequency electrical stimulation and R-verapamil on seizure susceptibility and glutamate and GABA release in a model of phenytoin-resistant seizures","volume":"61","author":"Luna-Munguia","year":"2011","journal-title":"Neuropharmacology"},{"issue":"3","key":"10.1016\/j.eplepsyres.2014.02.012_bib0070","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/S0022-3565(25)10138-9","article-title":"Evidence for anticonvulsant and neuroprotectant action of felbamate mediated by strychnine-insensitive glycine receptors","volume":"264","author":"McCabe","year":"1993","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"6","key":"10.1016\/j.eplepsyres.2014.02.012_bib0075","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1124\/mol.58.6.1357","article-title":"Xenobiotic transport across isolated brain microvessels studied by confocal microscopy","volume":"58","author":"Miller","year":"2000","journal-title":"Mol. Pharmacol."},{"issue":"3","key":"10.1016\/j.eplepsyres.2014.02.012_bib0080","first-page":"459","article-title":"Seizure-triggering mechanisms in the kindling model of epilepsy: collapse of GABA-mediated inhibition and activation of NMDA receptors","volume":"43","author":"Morimoto","year":"1989","journal-title":"Jpn. J. Psychiatry Neurol."},{"issue":"3","key":"10.1016\/j.eplepsyres.2014.02.012_bib0085","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1124\/jpet.109.152520","article-title":"Targeting prostaglandin E2 EP1 receptors prevents seizure-associated P-glycoprotein up-regulation","volume":"330","author":"Pekcec","year":"2009","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"6","key":"10.1016\/j.eplepsyres.2014.02.012_bib0090","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1038\/sj.bjp.0702172","article-title":"LU 73068, a new non-NMDA and glycine\/NMDA receptor antagonist: pharmacological characterization and comparison with NBQX and L-701,324 in the kindling model of epilepsy","volume":"125","author":"Potschka","year":"1998","journal-title":"Br. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.eplepsyres.2014.02.012_bib0095","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0304-3940(02)00423-8","article-title":"P-glycoprotein-mediated efflux of phenobarbital, lamotrigine, and felbamate at the blood\u2013brain barrier: evidence from microdialysis experiments in rats","volume":"327","author":"Potschka","year":"2002","journal-title":"Neurosci. Lett."},{"issue":"8","key":"10.1016\/j.eplepsyres.2014.02.012_bib0100","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1111\/j.1528-1167.2010.02585.x","article-title":"Modulating P-glycoprotein regulation: future perspectives for pharmacoresistant epilepsies?","volume":"51","author":"Potschka","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2014.02.012_bib0105","article-title":"CNS transporters and drug delivery in epilepsy","author":"Potschka","year":"2013","journal-title":"Curr. Pharm. Des."},{"issue":"3","key":"10.1016\/j.eplepsyres.2014.02.012_bib0110","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0013-4694(72)90177-0","article-title":"Modification of seizure activity by electrical stimulation. II. Motor seizure","volume":"32","author":"Racine","year":"1972","journal-title":"Electroencephalogr. Clin. Neurophysiol."},{"issue":"5","key":"10.1016\/j.eplepsyres.2014.02.012_bib0115","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1535-7511.2008.00272.x","article-title":"Intrinsic severity as a determinant of antiepileptic drug refractoriness","volume":"8","author":"Rogawski","year":"2008","journal-title":"Epilepsy Curr."},{"issue":"5","key":"10.1016\/j.eplepsyres.2014.02.012_bib0120","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1111\/j.1476-5381.2010.00765.x","article-title":"Celecoxib treatment restores pharmacosensitivity in a rat model of pharmacoresistant epilepsy","volume":"160","author":"Schlichtiger","year":"2010","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.eplepsyres.2014.02.012_bib0125","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0920-1211(03)00035-4","article-title":"Elevated extracellular levels of glutamate, aspartate and gamma-aminobutyric acid within the intraoperative, spontaneously epileptiform human hippocampus","volume":"54","author":"Thomas","year":"2003","journal-title":"Epilepsy Res."},{"issue":"1","key":"10.1016\/j.eplepsyres.2014.02.012_bib0130","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.surneu.2004.02.031","article-title":"Microdialysis of the lateral and medial temporal lobe during temporal lobe epilepsy surgery","volume":"63","author":"Thomas","year":"2005","journal-title":"Surg. Neurol."},{"issue":"2","key":"10.1016\/j.eplepsyres.2014.02.012_bib0135","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.neuropharm.2009.09.012","article-title":"COX-2 inhibition controls P-glycoprotein expression and promotes brain delivery of phenytoin in chronic epileptic rats","volume":"58","author":"van Vliet","year":"2010","journal-title":"Neuropharmacology"},{"issue":"4","key":"10.1016\/j.eplepsyres.2014.02.012_bib0140","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1369\/jhc.4A6451.2005","article-title":"Immunohistochemical localization of P-glycoprotein in rat brain and detection of its increased expression by seizures are sensitive to fixation and staining variables","volume":"53","author":"Volk","year":"2005","journal-title":"J. Histochem. Cytochem."},{"issue":"1","key":"10.1016\/j.eplepsyres.2014.02.012_bib0145","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.eplepsyres.2003.12.009","article-title":"Increased expression of the multidrug transporter P-glycoprotein in limbic brain regions after amygdala-kindled seizures in rats","volume":"58","author":"Volk","year":"2004","journal-title":"Epilepsy Res."},{"issue":"1","key":"10.1016\/j.eplepsyres.2014.02.012_bib0150","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0014-2999(97)01452-0","article-title":"Weak anticonvulsant effects of two novel glycineB receptor antagonists in the amygdala-kindling model in rats","volume":"342","author":"Wlaz","year":"1998","journal-title":"Eur. J. Pharmacol."},{"issue":"10","key":"10.1016\/j.eplepsyres.2014.02.012_bib0155","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1111\/j.1528-1167.2011.03140.x","article-title":"In vitro transport profile of carbamazepine, oxcarbazepine, eslicarbazepine acetate, and their active metabolites by human P-glycoprotein","volume":"52","author":"Zhang","year":"2011","journal-title":"Epilepsia"},{"issue":"10","key":"10.1016\/j.eplepsyres.2014.02.012_bib0160","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.addr.2011.12.003","article-title":"The transport of antiepileptic drugs by P-glycoprotein","volume":"64","author":"Zhang","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"7","key":"10.1016\/j.eplepsyres.2014.02.012_bib0165","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1111\/epi.12158","article-title":"Potential role for human P-glycoprotein in the transport of lacosamide","volume":"54","author":"Zhang","year":"2013","journal-title":"Epilepsia"},{"issue":"5","key":"10.1016\/j.eplepsyres.2014.02.012_bib0175","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.neuropharm.2009.01.009","article-title":"Prevention of seizure-induced up-regulation of endothelial P-glycoprotein by COX-2 inhibition","volume":"56","author":"Zibell","year":"2009","journal-title":"Neuropharmacology"}],"container-title":["Epilepsy Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121114000655?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121114000655?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T13:30:23Z","timestamp":1760275823000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920121114000655"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["S0920121114000655"],"URL":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2014.02.012","relation":{},"ISSN":["0920-1211"],"issn-type":[{"value":"0920-1211","type":"print"}],"subject":[],"published":{"date-parts":[[2014,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pre-treatment with the NMDA receptor glycine-binding site antagonist L-701,324 improves pharmacosensitivity in a mouse kindling model","name":"articletitle","label":"Article Title"},{"value":"Epilepsy Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2014.02.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}